Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
gJzVXTvpqsRjxkWH
Listen
